Los puntos clave no están disponibles para este artículo en este momento.
Neoadjuvant and adjuvant immunotherapies for cancer have evolved through a series of remarkable and critical research advances; however, addressing their similarities and differences is imperative in clinical practice. Therefore, this study aimed to examine their similarities and differences from the perspective of informatics analysis.
Guo et al. (Tue,) studied this question.